MGMT and obesity due to melanocortin 4 receptor deficiency: The finding of a negative effect of obesity on OS, at least in MGMT-methylated patients, is in line with a previous publication showing an association of obesity with reduced OS in a large retrospective case–control study [9], but inconsistent with results from a recent meta-analysis [20].